Nuvation Bio Inc Sustainability Reports
Nuvation Bio Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic candidates for cancer treatment. Its lead portfolio targets unmet medical needs in oncology through next-generation inhibitors and drug-drug conjugate platforms.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: 2549009IT4XP2SCZTR55
FIGI: BBG00VHJ0CD0
4 reports from 2021 to 2025
